Nanopharmaceuticals II: Application of nanoparticles and nanocarrier systems in pharmaceutics and nanomedicine

International Journal of Nanotechnology

Volumn 8, Issue 1-2, 2011, Pages 115-145

  Wu, Xiao ^a   Mansour, Heidi M ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Chemotherapy; Diagnostics; Multifunctional; Nanomedicine; Nanoparticles; Photodynamic therapy; Theragnostics; Therapeutics; Vaccination

Indexed keywords

CHEMOTHERAPY; CONTROLLED DRUG DELIVERY; DIAGNOSIS; DRUG INTERACTIONS; MEDICAL NANOTECHNOLOGY; NANOPARTICLES; NANOSYSTEMS; PHOTODYNAMIC THERAPY; PLASMA DIAGNOSTICS; VACCINES;

BIOLOGICAL PROPERTIES; MULTI-FUNCTIONAL NANOCARRIERS; MULTIFUNCTIONAL; NANOPARTICULATE SYSTEM; PHARMACEUTICAL DELIVERY; THERAGNOSTICS; THERAPEUTICS; VACCINATION;

TARGETED DRUG DELIVERY;

EID: 78649711455     PISSN: 14757435     EISSN: None     Source Type: Journal    
DOI: 10.1504/IJNT.2011.037173     Document Type: Article

References (220)

1. Perez, C., Castellanos, I.J., Costantino, H.R., Al-Azzam, W. and Griebenow, K. (2002) 'Recent trends in stabilizing protein structure upon encapsulation and release from bioerodible polymers', J. Pharm. Pharmacol., Vol. 54, No. 3, pp.301-313.
2. Krishnamachari, Y. and Salem, A.K. (2009) 'Innovative strategies for co-delivering antigens and CpG oligonucleotides', Adv. Drug Delivery Rev., Vol. 61, No. 3, pp.205-217.
3. Malik, D.K., Baboota, S., Ahuja, A., Hasan, S. and Ali, J. (2007) 'Recent advances in protein and peptide drug delivery systems', Curr. Drug Delivery, Vol. 4, No. 2, pp.141-151.
4. Misumi, S., Masuyama, M., Takamune, N., Nakayama, D., Mitsumata, R., Matsumoto, H., Urata, N., Takahashi, Y., Muneoka, A., Sukamoto, T., Fukuzaki, K. and Shoji, S. (2009) 'Targeted delivery of immunogen to primate m cells with tetragalloyl lysine dendrimer', J. Immunol., Vol. 182, No. 10, pp.6061-6070.
5. Fievez, V., Plapied, L., des Rieux, A., Pourcelle, V., Freichels, H., Wascotte, V., Vanderhaeghen, M.L., Jerome, C., Vanderplasschen, A., Marchand-Brynaert, J., Schneider, Y.J. and Preat, V. (2009) 'Targeting nanoparticles to M cells with non-peptidic ligands for oral vaccination', Eur. J. Pharm. Biopharm., Vol. 73, No. 1, pp.16-24.
6. Tobio, M., Gref, R., Sanchez, A., Langer, R. and Alonso, M.J. (1998) 'Stealth PLA-PEG nanoparticles as protein carriers for nasal administration', Pharm. Res., Vol. 15, No. 2, pp.270-275.
7. Csaba, N., Garcia-Fuentes, M. and Alonso, M.J. (2006) 'The performance of nanocarriers for transmucosal drug delivery', Expert Opin. Drug Deliv., Vol. 3, No. 4, pp.463-478.
8. Jain, A.K., Goyal, A.K., Gupta, P.N., Khatri, K., Mishra, N., Mehta, A., Mangal, S. and Vyas, S.P. (2009) 'Synthesis, characterization and evaluation of novel triblock copolymer based nanoparticles for vaccine delivery against hepatitis B', J. Control Release, Vol. 136, No. 2, pp.161-169.
9. Slutter, B., Plapied, L., Fievez, V., Sande, M.A., des Rieux, A., Schneider, Y.J., Van Riet, E., Jiskoot, W. and Preat, V. (2009) 'Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination', J. Control Release, Vol. 138, No. 2, pp.113-121.
10. Csaba, N., Garcia-Fuentes, M. and Alonso, M.J. (2009) 'Nanoparticles for nasal vaccination', Adv. Drug Delivery Rev., Vol. 61, No. 2, pp.140-157.
11. Yang, K., Whalen, B.J., Tirabassi, R.S., Selin, L.K., Levchenko, T.S., Torchilin, V.P., Kislauskis, E.H. and Guberski, D.L. (2008) 'A DNA vaccine prime followed by a liposome-encapsulated protein boost confers enhanced mucosal immune responses and protection', J. Immunol., Vol. 180, No. 9, pp.6159-6167.
12. Nayak, B., Panda, A.K., Ray, P. and Ray, A.R. (2009) 'Formulation, characterization and evaluation of rotavirus encapsulated PLA and PLGA particles for oral vaccination', J. Microencapsulation, Vol. 26, No. 2, pp.154-165.
13. Russell-Jones, G.J. (2000) 'Oral vaccine delivery, J. Control Release, Vol. 65, Nos. 1-2, pp.49-54.
14. Mahe, B., Vogt, A., Liard, C., Duffy, D., Abadie, V., Bonduelle, O., Boissonnas, A., Sterry, W., Verrier, B., Blume-Peytavi, U. and Combadiere, B. (2009) 'Nanoparticle-based targeting of vaccine compounds to skin antigen-presenting cells by hair follicles and their transport in mice', J. Invest. Dermatol., Vol. 129, No. 5, pp.1156-1164.
15. Mahor, S., Rawat, A., Dubey, P.K., Gupta, P.N., Khatri, K., Goyal, A.K. and Vyas, S.P. (2007) 'Cationic transfersomes based topical genetic vaccine against hepatitis B', Int. J. Pharm., Vol. 340, Nos. 1-2, pp.13-19.
16. Lawson, L.B., Freytag, L.C. and Clements, J.D. (2007) 'Use of nanocarriers for transdermal vaccine delivery', Clin. Pharmacol. Ther., Vol. 82, No. 6, pp.641-643.
17. de Haan, A., Tomee, J.F., Huchshorn, J.P. and Wilschut, J. (1995) 'Liposomes as an immunoadjuvant system for stimulation of mucosal and systemic antibody responses against inactivated measles virus administered intranasally to mice', Vaccine, Vol. 13, No. 14, pp.1320-1324.
18. Sloat, B.R. and Cui, Z. (2006) 'Strong mucosal and systemic immunities induced by nasal immunization with anthrax protective antigen protein incorporated in liposome-protamine- DNA particles', Pharm. Res., Vol. 23, No. 2, pp.262-269. (Pubitemid 43237857)
19. Ambrosch, F., Wiedermann, G., Jonas, S., Althaus, B., Finkel, B., Gluck, R. and Herzog, C. (1997) 'Immunogenicity and protectivity of a new liposomal hepatitis A vaccine', Vaccine, Vol. 15, No. 11, pp.1209-1213.
20. Chen, W., Yan, W. and Huang, L. (2008) 'A simple but effective cancer vaccine consisting of an antigen and a cationic lipid', Cancer Immunol. Immunother., Vol. 57, No. 4, pp.517-530.
21. Yan, W., Chen, W. and Huang, L. (2007) 'Mechanism of adjuvant activity of cationic liposome: phosphorylation of a MAP kinase, ERK and induction of chemokines', Mol. Immunol., Vol. 44, No. 15, pp.3672-3681.
22. Yan, W. and Huang, L. (2009) 'The effects of salt on the physicochemical properties and immunogenicity of protein based vaccine formulated in cationic liposome', Int. J. Pharm., Vol. 368, Nos. 1-2, pp.56-62.
23. Chen, W. and Huang, L. (2008) 'Induction of cytotoxic T-lymphocytes and antitumour activity by a liposomal lipopeptide vaccine', Mol. Pharm., Vol. 5, No. 3, pp.464-471.
24. Moffatt, S. and Cristiano, R.J. (2006) 'Uptake characteristics of NGR-coupled stealth PEI/pDNA nanoparticles loaded with PLGA-PEG-PLGA tri-block copolymer for targeted delivery to human monocyte-derived dendritic cells', Int. J. Pharm., Vol. 321, Nos. 1-2, pp.143-154.
25. Aline, F., Brand, D., Pierre, J., Roingeard, P., Severine, M., Verrier, B. and Dimier-Poisson, I. (2009) 'Dendritic cells loaded with HIV-1 p24 proteins adsorbed on surfactant-free anionic PLA nanoparticles induce enhanced cellular immune responses against HIV-1 after vaccination', Vaccine, Vol. 27, No. 38, pp.5284-5291.
26. Ataman-Onal, Y., Munier, S., Ganee, A., Terrat, C., Durand, P.Y., Battail, N., Martinon, F., Le Grand, R., Charles, M.H., Delair, T. and Verrier, B. (2006) 'Surfactant-free anionic PLA nanoparticles coated with HIV-1 p24 protein induced enhanced cellular and humoral immune responses in various animal models', J. Control Release, Vol. 112, No. 2, pp.175-185.
27. Bivas-Benita, M., Lin, M.Y., Bal, S.M., van Meijgaarden, K.E., Franken, K.L., Friggen, A.H., Junginger, H.E., Borchard, G., Klein, M.R. and Ottenhoff, T.H. (2009) 'Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA-PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice', Vaccine, Vol. 27, No. 30, pp.4010-4017.
28. Hamdy, S., Molavi, O., Ma, Z., Haddadi, A., Alshamsan, A., Gobti, Z., Elhasi, S., Samuel, J. and Lavasanifar, A. (2008) 'Co-delivery of cancer-associated antigen and Toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8+ T cell-mediated anti-tumor immunity', Vaccine, Vol. 26, No. 39, pp.5046-5057.
29. Hamdy, S., Elamanchili, P., Alshamsan, A., Molavi, O., Satou, T. and Samuel, J. (2007) 'Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D,L-lactic-co-glycolic acid) nanoparticles', J. Biomed. Mater. Res., Part A, Vol. 81, No. 3, pp.652-662.
30. Gref, R., Minamitake, Y., Peracchia, M.T., Trubetskoy, V., Torchilin, V. and Langer, R. (1994) 'Biodegradable long-circulating polymeric nanospheres', Science, Vol. 263, No. 5153, pp.1600-1603.
31. Vila, A., Sanchez, A., Tobio, M., Calvo, P. and Alonso, M.J. (2002) 'Design of biodegradable particles for protein delivery', J. Control Release, Vol. 78, Nos. 1-3, pp.15-24.
32. Vila, A., Sánchez, A., Pérez, C. and Alonso, M.J. (2002) 'PLA-PEG nanospheres: new carriers for transmucosal delivery of proteins and plasmid DNA', Polym. Adv. Technol., Vol. 13, Nos. 10-12, pp.851-858.
33. Hu, K.F., Lovgren-Bengtsson, K. and Morein, B. (2001) 'Immunostimulating complexes (ISCOMs) for nasal vaccination', Adv. Drug Delivery Rev., Vol. 51, Nos. 1-3, pp.149-159.
34. Saupe, A., McBurney, W., Rades, T. and Hook, S. (2006) 'Immunostimulatory colloidal delivery systems for cancer vaccines', Expert Opin. Drug Deliv., Vol. 3, No. 3, pp.345-354.
35. Scheerlinck, J.P. and Greenwood, D.L. (2008) 'Virus-sized vaccine delivery systems', Drug Discovery Today, Vol. 13, Nos. 19-20, pp.882-887.
36. Sjolander, S., Drane, D., Davis, R., Beezum, L., Pearse, M. and Cox, J. (2001) 'Intranasal immunisation with influenza-ISCOM induces strong mucosal as well as systemic antibody and cytotoxic T-lymphocyte responses', Vaccine, Vol. 19, Nos. 28-29, pp.4072-4080.
37. Pearse, M.J. and Drane, D. (2005) 'ISCOMATRIX adjuvant for antigen delivery', Adv. Drug Delivery Rev., Vol. 57, No. 3, pp.465-474.
38. Mowat, A.M. (2005) 'Dendritic cells and immune responses to orally administered antigens', Vaccine, Vol. 23, No. 15, pp.1797-1799.
39. Robson, N.C., Beacock-Sharp, H., Donachie, A.M. and Mowat, A.M. (2003) 'The role of antigen-presenting cells and interleukin-12 in the priming of antigen-specific CD4+ T cells by immune stimulating complexes', Immunology, Vol. 110, No. 1, pp.95-104.
40. Beacock-Sharp, H., Donachie, A.M., Robson, N.C. and Mowat, A.M. (2003) 'A role for dendritic cells in the priming of antigen-specific CD4+ and CD8+ T lymphocytes by immune-stimulating complexes in vivo', Int. Immunol., Vol. 15, No. 6, pp.711-720.
41. Brigger, I., Dubernet, C. and Couvreur, P. (2002) 'Nanoparticles in cancer therapy and diagnosis', Adv. Drug Delivery Rev., Vol. 54, No. 5, pp.631-651.
42. Fattal, E., Vauthier, C., Aynie, I., Nakada, Y., Lambert, G., Malvy, C. and Couvreur, P. (1998) 'Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides', J. Control Release, Vol. 53, Nos. 1-3, pp.137-143.
43. ElBayoumi, T.A. and Torchilin, V.P. (2009) 'Tumor-targeted nanomedicines: enhanced antitumor efficacy in vivo of doxorubicin-loaded, long-circulating liposomes modified with cancer-specific monoclonal antibody', Clin. Cancer Res., Vol. 15, No. 6, pp.1973-1980.
44. Sawant, R.M., Cohen, M.B., Torchilin, V.P. and Rokhlin, O.W. (2008) 'Prostate cancer-specific monoclonal antibody 5D4 significantly enhances the cytotoxicity of doxorubicin-loaded liposomes against target cells in vitro', J. Drug Targeting, Vol. 16, No. 7, pp.601-604.
45. Elbayoumi, T.A. and Torchilin, V.P. (2009) 'Tumor-specific anti-nucleosome antibody improves therapeutic efficacy of doxorubicin-loaded long-circulating liposomes against primary and metastatic tumor in mice', Mol. Pharm., Vol. 6, No. 1, pp.246-254.
46. Patil, Y., Sadhukha, T., Ma, L. and Panyam, J. (2009) 'Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance', J. Control Release, Vol. 136, No. 1, pp.21-29.
47. Danhier, F., Lecouturier, N., Vroman, B., Jerome, C., Marchand-Brynaert, J., Feron, O. and Preat, V. (2009) 'Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation', J. Control Release, Vol. 133, No. 1, pp.11-17.
48. Stein, W.D., Bates, S.E. and Fojo, T. (2004) 'Intractable cancers: the many faces of multidrug resistance and the many targets it presents for therapeutic attack', Curr. Drug Targets, Vol. 5, No. 4, pp.333-346.
49. Kirkin, V., Joos, S. and Zornig, M. (2004) 'The role of Bcl-2 family members in tumorigenesis', Biochim. Biophys. Acta, Vol. 1644, Nos. 2-3, pp.229-249.
50. Calderwood, S.K., Khaleque, M.A., Sawyer, D.B. and Ciocca, D.R. (2006) 'Heat shock proteins in cancer: chaperones of tumorigenesis', Trends Biochem. Sci., Vol. 31, No. 3, pp.164-172.
51. O'Connor, R. (2007) 'The pharmacology of cancer resistance', Anticancer Res., Vol. 27, No. 3A, pp.1267-1272.
52. Lage, H. (2006) 'MDR1/P-glycoprotein (ABCB1) as target for RNA interference-mediated reversal of multidrug resistance', Curr. Drug Targets, Vol. 7, No. 7, pp.813-821.
53. Dong, X., Mattingly, C.A., Tseng, M.T., Cho, M.J., Liu, Y., Adams, V.R. and Mumper, R.J. (2009) 'Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP', Cancer Res., Vol. 69, No. 9, pp.3918-3926.
54. Ma, P., Dong, X., Swadley, C.L., Gupte, A., Leggas, M., Ledebur, H.C. and Mumper, R.J. (2009) 'Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome Pgp-mediated multiple drug resistance in leukemia', J. Biomed. Nanotechnol., Vol. 5, No. 2, pp.151-161.
55. Dong, X., Mattingly, C.A., Tseng, M., Cho, M., Adams, V.R. and Mumper, R.J. (2009) 'Development of new lipid-based paclitaxel nanoparticles using sequential simplex optimization', Eur. J. Pharm. Biopharm., Vol. 72, No. 1, pp.9-17.
56. Fox, E. and Bates, S.E. (2007) 'Tariquidar (XR9576): a P-glycoprotein drug efflux pump inhibitor', Expert Rev. Anticancer Ther., Vol. 7, pp.447-459.
57. Morschhauser, F., Zinzani, P.L., Burgess, M., Sloots, L., Bouafia, F. and Dumontet, C. (2007) 'Phase I/II trial of a P-glycoprotein inhibitor, Zosuquidar.3HCl trihydrochloride (LY335979), given orally in combination with the CHOP regimen in patients with non-Hodgkin's lymphoma', Leuk. Lymphoma, Vol. 48, No. 4, pp.708-715.
58. Moghimi, S.M., Hunter, A.C. and Murray, J.C. (2005) 'Nanomedicine: current status and future prospects', FASEB J., Vol. 19, No. 3, pp.311-330.
59. Gibaud, S., Andreux, J.P., Weingarten, C., Renard, M. and Couvreur, P. (1994) 'Increased bone marrow toxicity of doxorubicin bound to nanoparticles', Eur. J. Cancer, Vol. 30A, No. 6, pp.820-826.
60. Chen, H., MacDonald, R.C., Li, S., Krett, N.L., Rosen, S.T. and O'Halloran, T.V. (2006) 'Lipid encapsulation of arsenic trioxide attenuates cytotoxicity and allows for controlled anticancer drug release', J. Am. Chem. Soc., Vol. 128, No. 41, pp.13348-13349.
61. Qi, L., Xu, Z. and Chen, M. (2007) 'In vitro and in vivo suppression of hepatocellular carcinoma growth by chitosan nanoparticles', Eur. J. Cancer, Vol. 43, No. 1, pp.184-193.
62. Chiannilkulchai, N., Driouich, Z., Benoit, J.P., Parodi, A.L. and Couvreur, P. (1989) 'Doxorubicin-loaded nanoparticles: increased efficiency in murine hepatic metastasis', Sel. Cancer Ther., Vol. 5, pp.1-11.
63. Chiannilkulchai, N., Ammoury, N., Caillou, B., Devissaguet, J. and Couvreur, P. (1990) 'Hepatic tissue distribution of doxorubicin-loaded nanoparticles after i.v. administration in reticulosarcoma M 5076 metastasis-bearing mice', Cancer Chemother. Pharmacol., Vol. 26, No. 2, pp.122-126.
64. Storm, G., Belliot, S.O., Daemen, T. and Lasic, D.D. (1995) 'Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system', Adv. Drug Delivery Rev., Vol. 17, No. 1, pp.31-48.
65. Gulyaev, A.E., Gelperina, S.E., Skidan, I.N., Antropov, A.S., Kivman, G.Y. and Kreuter, J. (1999) 'Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles', Pharm. Res., Vol. 16, No. 10, pp.1564-1569.
66. Lode, J., Fichtner, I., Kreuter, J., Berndt, A., Diederichs, J.E. and Reszka, R. (2001) 'Influence of surface-modifying surfactants on the pharmacokinetic behavior of 14C-poly (methylmethacrylate) nanoparticles in experimental tumor models', Pharm. Res., Vol. 18, No. 11, pp.1613-1619.
67. Kaul, G. and Amiji, M. (2004) 'Biodistribution and targeting potential of poly(ethylene glycol)-modified gelatin nanoparticles in subcutaneous murine tumor model', J. Drug Targeting, Vol. 12, Nos. 9-10, pp.585-591.
68. Kaul, G. and Amiji, M. (2002) 'Long-circulating poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery', Pharm. Res., Vol. 19, No. 7, pp.1061-1067.
69. Rose, P.G. (2005) 'Pegylated liposomal doxorubicin: optimizing the dosing schedule in ovarian cancer', Oncologist, Vol. 10, No. 3, pp.205-214.
70. Prabaharan, M., Grailer, J.J., Pilla, S., Steeber, D.A. and Gong, S. (2009) 'Folate-conjugated amphiphilic hyperbranched block copolymers based on Boltorn H40, poly(L-lactide) and poly(ethylene glycol) for tumor-targeted drug delivery', Biomaterials, Vol. 30, No. 16, pp.3009-3019.
71. Park, J., Fong, P.M., Lu, J., Russell, K.S., Booth, C.J., Saltzman, W.M. and Fahmy, T.M. (2009) 'PEGylated PLGA nanoparticles for the improved delivery of doxorubicin', Nanomedicine, Vol. 5, No. 4, pp.410-418.
72. Allen, T.M., Mehra, T., Hansen, C. and Chin, Y.C. (1992) 'Stealth liposomes: an improved sustained release system for 1-beta-D- arabinofuranosylcytosine', Cancer Res., Vol. 52, No. 9, pp.2431-2439.
73. Boman, N.L., Masin, D., Mayer, L.D., Cullis, P.R. and Bally, M.B. (1994) 'Liposomal vincristine which exhibits increased drug retention and increased circulation longevity cures mice bearing P388 tumors', Cancer Res., Vol. 54, No. 11, pp.2830-2833.
74. Davaran, S., Rashidi, M.R., Pourabbas, B., Dadashzadeh, M. and Haghshenas, N.M. (2006) 'Adriamycin release from poly(lactide-coglycolide)- polyethylene glycol nanoparticles: synthesis, and in vitro characterization', Int. J. Nanomed., Vol. 1, No. 4, pp.535-539.
75. Danhier, F., Vroman, B., Lecouturier, N., Crokart, N., Pourcelle, V., Freichels, H., Jerome, C., Marchand-Brynaert, J., Feron, O. and Preat, V. (2009) 'Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with Paclitaxel', J. Control Release, Vol. 140, No. 2, pp.166-173.
76. Gindy, M.E. and Prud'homme, R.K. (2009) 'Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy', Expert Opin. Drug Deliv., Vol. 6, No. 8, pp.865-878.
77. Tseng, H.Y., Lee, G.B., Lee, C.Y., Shih, Y.H. and Lin, X.Z. (2009) 'Localised heating of tumours utilising injectable magnetic nanoparticles for hyperthermia cancer therapy', IET Nanobiotechnol., Vol. 3, No. 2, pp.46-54.
78. Hou, C.H., Hou, S.M., Hsueh, Y.S., Lin, J., Wu, H.C. and Lin, F.H. (2009) 'The in vivo performance of biomagnetic hydroxyapatite nanoparticles in cancer hyperthermia therapy', Biomaterials, Vol. 30, Nos. 23-24, pp.3956-3960.
79. Santra, S., Kaittanis, C., Grimm, J. and Perez, J.M. (2009) 'Drug/dye-loaded, multifunctional iron oxide nanoparticles for combined targeted cancer therapy and dual optical/magnetic resonance imaging', Small, Vol. 5, No. 16, pp.1862-1868.
80. Moroz, P., Jones, S.K. and Gray, B.N. (2002) 'Magnetically mediated hyperthermia: current status and future directions', Int. J. Hyperthermia, Vol. 18, No. 4, pp.267-284.
81. Van der Zee, J. (2002) 'Heating the patient: a promising approach?', Ann. Oncol., Vol. 13, No. 8, pp.1173-1184.
82. Minamimura, T., Sato, H., Kasaoka, S., Saito, T., Ishizawa, S., Takemori, S., Tazawa, K. and Tsukada, K. (2000) 'Tumor regression by inductive hyperthermia combined with hepatic embolization using dextran magnetite-incorporated microspheres in rats', Int. J. Oncol., Vol. 16, No. 6, pp.1153-1158.
83. Babincov, M., Altanerov, V., Altaner, C., Bergemann, C. and Babinec, P. (2008) 'In vitro analysis of cisplatin functionalized magnetic nanoparticles in combined cancer chemotherapy and electromagnetic hyperthermia', IEEE Trans. Nanobiosci., Vol. 7, No. 1, pp.15-19.
84. Ito, A., Fujioka, M., Yoshida, T., Wakamatsu, K., Ito, S., Yamashita, T., Jimbow, K. and Honda, H. (2007) '4-S-Cysteaminylphenol-loaded magnetite cationic liposomes for combination therapy of hyperthermia with chemotherapy against malignant melanoma', Cancer Sci., Vol. 98, No. 3, pp.424-430.
85. Purushotham, S., Chang, P.E., Rumpel, H., Kee, I.H., Ng, R.T., Chow, P.K., Tan, C.K. and Ramanujan, R.V. (2009) 'Thermoresponsive core-shell magnetic nanoparticles for combined modalities of cancer therapy', Nanotechnology, Vol. 20, No. 30, p.305101.
86. Fritsch, C., Goerz, G. and Ruzicka, T. (1998) 'Photodynamic therapy in dermatology', Arch. Dermatol., Vol. 134, No. 2, pp.207-214.
87. Peng, Q., Warloe, T., Berg, K., Moan, J., Kongshaug, M., Giercksky, K.E. and Nesland, J.M. (1997) '5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges', Cancer, Vol. 79, No. 12, pp.2282-2308. (Pubitemid 27251011)
88. Ma, L., Bagdonas, S. and Moan, J. (2001) 'The photosensitizing effect of the photoproduct of protoporphyrin IX', J. Photochem. Photobiol., B, Vol. 60, Nos. 2-3, pp.108-113.
89. Gomes, E.R., Cruz, T., Lopes, C.F., Carvalho, A.P. and Duarte, C.B. (1999) 'Photosensitization of lymphoblastoid cells with phthalocyanines at different saturating incubation times', Cell Biol. Toxicol., Vol. 15, No. 4, pp.249-260.
90. Stockert, J.C., Canete, M., Juarranz, A., Villanueva, A., Horobin, R.W., Borrell, J.I., Teixido, J. and Nonell, S. (2007) 'Porphycenes: facts and prospects in photodynamic therapy of cancer', Curr. Med. Chem., Vol. 14, No. 9, pp.997-1026.
91. Pass, H.I. (1993) 'Photodynamic therapy in oncology: mechanisms and clinical use', J. Natl. Cancer Inst., Vol. 85, No. 6, pp.443-456.
92. Fisher, A.M., Murphree, A.L. and Gomer, C.J. (1995) 'Clinical and preclinical photodynamic therapy', Lasers Surg. Med., Vol. 17, No. 1, pp.2-31.
93. Chatterjee, D.K., Fong, L.S. and Zhang, Y. (2008) 'Nanoparticles in photodynamic therapy: an emerging paradigm', Adv. Drug Delivery Rev., Vol. 60, No. 15, pp.1627-1637.
94. Florence, A.T. and Hussain, N. (2001) 'Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas', Adv. Drug Delivery Rev., Vol. 50, Suppl. 1, pp.S69-89.
95. Ricci-Junior, E. and Marchetti, J.M. (2006) 'Zinc(II) phthalocyanine loaded PLGA nanoparticles for photodynamic therapy use', Int. J. Pharm., Vol. 310, Nos. 1-2, pp.187-195.
96. Yan, F. and Kopelman, R. (2003) 'The embedding of meta- tetra(hydroxyphenyl)-chlorin into silica nanoparticle platforms for photodynamic therapy and their singlet oxygen production and pH-dependent optical properties', Photochem. Photobiol., Vol. 78, No. 6, pp.587-591.
97. Roy, I., Ohulchanskyy, T.Y., Pudavar, H.E., Bergey, E.J., Oseroff, A.R., Morgan, J., Dougherty, T.J. and Prasad, P.N. (2003) 'Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy', J. Am. Chem. Soc., Vol. 125, No. 26, pp.7860-7865.
98. Tang, W., Xu, H., Park, E.J., Philbert, M.A. and Kopelman, R. (2008) 'Encapsulation of methylene blue in polyacrylamide nanoparticle platforms protects its photodynamic effectiveness', Biochem. Biophys. Res. Commun., Vol. 369, No. 2, pp.579-583.
99. Gao, D., Agayan, R.R., Xu, H., Philbert, M.A. and Kopelman, R. (2006) 'Nanoparticles for two-photon photodynamic therapy in living cells', Nano Lett., Vol. 6, No. 11, pp.2383-2386.
100. Cheng, Y., Samia, A.C., Meyers, J.D., Panagopoulos, I., Fei, B. and Burda, C. (2008) 'Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer', J. Am. Chem. Soc., Vol. 130, No. 32, pp.10643-10647.
101. Heer, S., Kompe, K., Gudel, H.U. and Haase, M. (2004) 'Highly efficient multicolour upconversion emission in transparent colloids of lanthanide-doped NaYF4 nanocrystals', Adv. Mater., Vol. 16, Nos. 23-24, pp.2102-2105.
102. Samia, A.C., Chen, X. and Burda, C. (2003) 'Semiconductor quantum dots for photodynamic therapy', J. Am. Chem. Soc., Vol. 125, No. 51, pp.15736-15737.
103. Khdair, A., Handa, H., Mao, G. and Panyam, J. (2009) 'Nanoparticle- mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance in vitro', Eur. J. Pharm. Biopharm., Vol. 71, No. 2, pp.214-222.
104. Khdair, A., Gerard, B., Handa, H., Mao, G., Shekhar, M.P. and Panyam, J. (2008) 'Surfactant-polymer nanoparticles enhance the effectiveness of anticancer photodynamic therapy', Mol. Pharm., Vol. 5, No. 5, pp.795-807.
105. Chavanpatil, M.D., Khdair, A., Gerard, B., Bachmeier, C., Miller, D.W., Shekhar, M.P. and Panyam, J. (2007) 'Surfactant-polymer nanoparticles overcome P-glycoprotein-mediated drug efflux', Mol. Pharm., Vol. 4, No. 5, pp.730-738.
106. Shubayev, V.I., Pisanic II, T.R., and Jin, S. (2009) 'Magnetic nanoparticles for theragnostics', Adv. Drug Delivery Rev., Vol. 61, No. 6, pp.467-477.
107. Ito, A., Shinkai, M., Honda, H. and Kobayashi, T. (2005) 'Medical application of functionalized magnetic nanoparticles', J. Biosci. Bioeng., Vol. 100, No. 1, pp.1-11.
108. Arbab, A.S., Liu, W. and Frank, J.A. (2006) 'Cellular magnetic resonance imaging: current status and future prospects', Expert Rev. Med. Devices, Vol. 3, No. 4, pp.427-439.
109. McCarthy, J.R., Kelly, K.A., Sun, E.Y. and Weissleder, R. (2007) 'Targeted delivery of multifunctional magnetic nanoparticles', Nanomedicine, Vol. 2, No. 2, pp.153-167.
110. Chellat, F., Merhi, Y., Moreau, A. and Yahia, L. (2005) 'Therapeutic potential of nanoparticulate systems for macrophage targeting', Biomaterials, Vol. 26, No. 35, pp.7260-7275.
111. Kircher, M.F., Allport, J.R., Graves, E.E., Love, V., Josephson, L., Lichtman, A.H. and Weissleder, R. (2003) 'In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors', Cancer Res., Vol. 63, No. 20, pp.6838-6846.
112. Jain, T.K., Reddy, M.K., Morales, M.A., Leslie-Pelecky, D.L. and Labhasetwar, V. (2008) 'Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats', Mol. Pharm., Vol. 5, No. 2, pp.316-327.
113. Zhu, D., Lu, X., Hardy, P.A., Leggas, M. and Jay, M. (2008) 'Nanotemplate-engineered nanoparticles containing gadolinium for magnetic resonance imaging of tumors', Invest. Radiol., Vol. 43, No. 2, pp.129-140.
114. Zhu, D., White, R.D., Hardy, P.A., Weerapreeyakul, N., Sutthanut, K. and Jay, M. (2006) 'Biocompatible nanotemplate-engineered nanoparticles containing gadolinium: stability and relaxivity of a potential MRI contrast agent', J. Nanosci. Nanotechnol., Vol. 6, No. 4, pp.996-1003.
115. Erdogan, S., Medarova, Z.O., Roby, A., Moore, A. and Torchilin, V.P. (2008) 'Enhanced tumor MR imaging with gadolinium-loaded polychelating polymer-containing tumor-targeted liposomes', J. Magn. Reson. Imaging, Vol. 27, No. 3, pp.574-580.
116. Alonso, M.J. (2004) 'Nanomedicines for overcoming biological barriers', Biomed. Pharmacother., Vol. 58, No. 3, pp.168-172.
117. Torchilin, V.P. (2006) 'Multifunctional nanocarriers', Adv. Drug Delivery Rev., Vol. 58, No. 14, pp.1532-1555.
118. Torchilin, V.P. (2007) 'Nanocarriers', Pharm. Res., Vol. 24, No. 12, pp.2333-2334.
119. Allen, T.M., Hansen, C., Martin, F., Redemann, C. and Yau-Young, A. (1991) 'Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo', Biochim. Biophys. Acta, Vol. 1066, No. 1, pp.29-36.
120. Senior, J., Delgado, C., Fisher, D., Tilcock, C. and Gregoriadis, G. (1991) 'Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles', Biochim. Biophys. Acta, Vol. 1062, No. 1, pp.77-82.
121. Elbayoumi, T.A. and Torchilin, V.P. (2007) 'Enhanced cytotoxicity of monoclonal anticancer antibody 2C5-modified doxorubicin-loaded PEGylated liposomes against various tumor cell lines', Eur. J. Pharm. Sci., Vol. 32, No. 3, pp.159-168.
122. Wartlick, H., Michaelis, K., Balthasar, S., Strebhardt, K., Kreuter, J. and Langer, K. (2004) 'Highly specific HER2-mediated cellular uptake of antibody-modified nanoparticles in tumour cells', J. Drug Targeting, Vol. 12, No. 7, pp.461-471.
123. Ishida, O., Maruyama, K., Tanahashi, H., Iwatsuru, M., Sasaki, K., Eriguchi, M. and Yanagie, H. (2001) 'Liposomes bearing polyethyleneglycol- coupled transferrin with intracellular targeting property to the solid tumors in vivo', Pharm. Res., Vol. 18, No. 7, pp.1042-1048.
124. D'Souza, G.G., Wang, T., Rockwell, K. and Torchilin, V.P. (2008) 'Surface modification of pharmaceutical nanocarriers with ascorbate residues improves their tumor-cell association and killing and the cytotoxic action of encapsulated paclitaxel in vitro', Pharm. Res., Vol. 25, No. 11, pp.2567-2572.
125. Boddapati, S.V., D'Souza, G.G., Erdogan, S., Torchilin, V.P. and Weissig, V. (2008) 'Organelle-targeted nanocarriers: specific delivery of liposomal ceramide to mitochondria enhances its cytotoxicity in vitro and in vivo', Nano Lett., Vol. 8, No. 8, pp.2559-2563.
126. Stella, B., Arpicco, S., Peracchia, M.T., Desmaele, D., Hoebeke, J., Renoir, M., D'Angelo, J., Cattel, L. and Couvreur, P. (2000) 'Design of folic acid-conjugated nanoparticles for drug targeting', J. Pharm. Sci., Vol. 89, No. 11, pp.1452-1464.
127. Roux, E., Passirani, C., Scheffold, S., Benoit, J.P. and Leroux, J.C. (2004) 'Serum-stable and long-circulating, PEGylated, pH-sensitive liposomes', J. Control Release, Vol. 94, Nos. 2-3, pp.447-451.
128. Kale, A.A. and Torchilin, V.P. (2007) 'Design, synthesis, and characterization of pH-sensitive PEG-PE conjugates for stimuli-sensitive pharmaceutical nanocarriers: the effect of substitutes at the hydrazone linkage on the ph stability of PEG-PE conjugates', Bioconjugate Chem., Vol. 18, No. 2, pp.363-370.
129. Kale, A.A. and Torchilin, V.P. (2007) ''Smart' drug carriers: PEGylated TATp-modified pH-sensitive liposomes', J. Liposome Res., Vol. 17, Nos. 3-4, pp.197-203.
130. Kale, A.A. and Torchilin, V.P. (2007) 'Enhanced transfection of tumor cells in vivo using 'Smart' pH-sensitive TAT-modified pegylated liposomes', J. Drug Targeting, Vol. 15, Nos. 7-8, pp.538-545.
131. Batrakova, E.V. and Kabanov, A.V. (2008) 'Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers', J. Control Release, Vol. 130, No. 2, pp.98-106.
132. Kabanov, A., Zhu, J. and Alakhov, V. (2005) 'Pluronic block copolymers for gene delivery', Adv. Genet., Vol. 53PA, pp.231-261.
133. Verma, D.D., Hartner, W.C., Thakkar, V., Levchenko, T.S. and Torchilin, V.P. (2007) 'Protective effect of coenzyme Q10-loaded liposomes on the myocardium in rabbits with an acute experimental myocardial infarction', Pharm. Res., Vol. 24, No. 11, pp.2131-2137.
134. Torchilin, V.P. (2007) 'Tatp-mediated intracellular delivery of pharmaceutical nanocarriers', Biochem. Soc. Trans., Vol. 35, No. 4, pp.816-820.
135. Torchilin, V.P. (2008) 'Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers', Adv. Drug Delivery Rev., Vol. 60, Nos. 4-5, pp.548-558.
136. Gupta, B., Levchenko, T.S. and Torchilin, V.P. (2007) 'TAT peptide-modified liposomes provide enhanced gene delivery to intracranial human brain tumor xenografts in nude mice', Oncol. Res., Vol. 16, No. 8, pp.351-359.
137. Peetla, C., Rao, K.S. and Labhasetwar, V. (2009) 'Relevance of biophysical interactions of nanoparticles with a model membrane in predicting cellular uptake: study with TAT peptide-conjugated nanoparticles', Mol. Pharm., Vol. 6, No. 5, pp.1311-1320.
138. Peetla, C. and Labhasetwar, V. (2009) 'Effect of molecular structure of cationic surfactants on biophysical interactions of surfactant-modified nanoparticles with a model membrane and cellular uptake', Langmuir, Vol. 25, No. 4, pp.2369-2377.
139. Peetla, C. and Labhasetwar, V. (2008) 'Biophysical characterization of nanoparticleendothelial model cell membrane interactions', Mol. Pharm., Vol. 5, No. 3, pp.418-429.
140. Kunath, K., von Harpe, A., Fischer, D., Petersen, H., Bickel, U., Voigt, K. and Kissel, T. (2003) 'Low-molecular-weight polyethylenimine as a non-viral vector for DNA delivery: comparison of physicochemical properties, transfection efficiency and in vivo distribution with high-molecular-weight polyethylenimine', J. Control Release, Vol. 89, No. 1, pp.113-125.
141. Sakurai, F., Inoue, R., Nishino, Y., Okuda, A., Matsumoto, O., Taga, T., Yamashita, F., Takakura, Y. and Hashida, M. (2000) 'Effect of DNA/liposome mixing ratio on the physicochemical characteristics, cellular uptake and intracellular trafficking of plasmid DNA/cationic liposome complexes and subsequent gene expression', J. Control Release, Vol. 66, Nos. 2-3, pp.255-269.
142. Frankel, A.D. and Pabo, C.O. (1988) 'Cellular uptake of the tat protein from human immunodeficiency virus', Cell, Vol. 55, No. 6, pp.1189-1193.
143. Levchenko, T.S., Rammohan, R., Volodina, N. and Torchilin, V.P. (2003) 'Tat peptide-mediated intracellular delivery of liposomes', Methods Enzymol., Vol. 372, pp.339-349.
144. Wadia, J.S., Stan, R.V. and Dowdy, S.F. (2004) 'Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis', Nat. Med., Vol. 10, No. 3, pp.310-315.
145. Liu, J., Zhang, Q., Remsen, E.E. and Wooley, K.L. (2001) 'Nanostructured materials designed for cell binding and transduction', Biomacromolecules, Vol. 2, No. 2, pp.362-368.
146. Pappalardo, J.S., Quattrocchi, V., Langellotti, C., Di Giacomo, S., Gnazzo, V., Olivera, V., Calamante, G., Zamorano, P.I., Levchenko, T.S. and Torchilin, V.P. (2009) 'Improved transfection of spleen-derived antigen-presenting cells in culture using TATp-liposomes', J. Control Release, Vol. 134, No. 1, pp.41-46.
147. Ko, Y.T., Hartner, W.C., Kale, A. and Torchilin, V.P. (2009) 'Gene delivery into ischemic myocardium by double-targeted lipoplexes with anti-myosin antibody and TAT peptide', Gene Ther., Vol. 16, No. 1, pp.52-59.
148. Hyndman, L., Lemoine, J.L., Huang, L., Porteous, D.J., Boyd, A.C. and Nan, X. (2004) 'HIV-1 Tat protein transduction domain peptide facilitates gene transfer in combination with cationic liposomes', J. Control Release, Vol. 99, No. 3, pp.435-444.
149. Nitin, N., LaConte, L.E., Zurkiya, O., Hu, X. and Bao, G. (2004) 'Functionalization and peptide-based delivery of magnetic nanoparticles as an intracellular MRI contrast agent', J. Biol. Inorg. Chem., Vol. 9, No. 6, pp.706-712.
150. Gupta, B., Levchenko, T.S. and Torchilin, V.P. (2007) 'TAT peptide-modified liposomes provide enhanced gene delivery to intracranial human brain tumor xenografts in nude mice', Oncol. Res., Vol. 16, No. 8, pp.351-359.
151. Kleemann, E., Neu, M., Jekel, N., Fink, L., Schmehl, T., Gessler, T., Seeger, W. and Kissel, T. (2005) 'Nano-carriers for DNA delivery to the lung based upon a TAT-derived peptide covalently coupled to PEG-PEI', J. Control Release, Vol. 109, Nos. 1-3, pp.299-316.
152. Paschke, M. and Hohne, W. (2005) 'A twin-arginine translocation (Tat)-mediated phage display system', Gene, Vol. 350, No. 1, pp.79-88.
153. Cryan, S.A., Devocelle, M., Moran, P.J., Hickey, A.J. and Kelly, J.G. (2006) 'Increased intracellular targeting to airway cells using octaarginine-coated liposomes: in vitro assessment of their suitability for inhalation', Mol. Pharm., Vol. 3, No. 2, pp.104-112.
154. Sawant, R.M., Hurley, J.P., Salmaso, S., Kale, A., Tolcheva, E., Levchenko, T.S. and Torchilin, V.P. (2006) "SMART' drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers', Bioconjugate Chem.,
155. Gupta, B., Levchenko, T.S. and Torchilin, V.P. (2005) 'Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides', Adv. Drug Delivery Rev., Vol. 57, No. 4, pp.637-651.
156. Torchilin, V.P. (2008) 'Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery', Biopolymers, Vol. 90, No. 5, pp.604-610.
157. Takayama, K., Tadokoro, A., Pujals, S., Nakase, I., Giralt, E. and Futaki, S. (2009) 'Novel system to achieve one-pot modification of cargo molecules with oligoarginine vectors for intracellular delivery', Bioconjugate Chem., Vol. 20, No. 2, pp.249-257.
158. Nakase, I., Takeuchi, T., Tanaka, G. and Futaki, S. (2008) 'Methodological and cellular aspects that govern the internalization mechanisms of arginine-rich cell-penetrating peptides', Adv. Drug Delivery Rev., Vol. 60, Nos. 4-5, pp.598-607.
159. Fretz, M.M., Penning, N.A., Al-Taei, S., Futaki, S., Takeuchi, T., Nakase, I., Storm, G. and Jones, A.T. (2007) 'Temperature-, concentration- and cholesterol-dependent translocation of L- and D-octa-arginine across the plasma and nuclear membrane of CD34+ leukaemia cells', Biochem. J., Vol. 403, No. 2, pp.335-342.
160. Gupta, B. and Torchilin, V.P. (2006) 'Transactivating transcriptional activator-mediated drug delivery', Expert Opin. Drug Deliv., Vol. 3, No. 2, pp.177-190.
161. Astriab-Fisher, A., Sergueev, D., Fisher, M., Shaw, B.R. and Juliano, R.L. (2002) 'Conjugates of antisense oligonucleotides with the Tat and antennapedia cell-penetrating peptides: effects on cellular uptake, binding to target sequences, and biologic actions', Pharm. Res., Vol. 19, No. 6, pp.744-754.
162. Sugita, T., Yoshikawa, T., Mukai, Y., Yamanada, N., Imai, S., Nagano, K., Yoshida, Y., Shibata, H., Yoshioka, Y., Nakagawa, S., Kamada, H., Tsunoda, S.I. and Tsutsumi, Y. (2008) 'Comparative study on transduction and toxicity of protein transduction domains', Br. J. Pharmacol., Vol. 153, No. 6, pp.1143-1152.
163. Ishihara, T., Goto, M., Kodera, K., Kanazawa, H., Murakami, Y., Mizushima, Y. and Higaki, M. (2009) 'Intracellular delivery of siRNA by cell-penetrating peptides modified with cationic oligopeptides', Drug Delivery, Vol. 16, No. 3, pp.153-159.
164. Bendifallah, N., Rasmussen, F.W., Zachar, V., Ebbesen, P., Nielsen, P.E. and Koppelhus, U. (2006) 'Evaluation of cell-penetrating peptides (CPPs) as vehicles for intracellular delivery of antisense peptide nucleic acid (PNA)', Bioconjugate Chem., Vol. 17, No. 3, pp.750-758.
165. Zaro, J.L., Vekich, J.E., Tran, T. and Shen, W.C. (2009) 'Nuclear localization of cell-penetrating peptides is dependent on endocytosis rather than cytosolic delivery in CHO cells', Mol. Pharm., Vol. 6, No. 2, pp.337-344.
166. Beduneau, A., Ma, Z., Grotepas, C.B., Kabanov, A., Rabinow, B.E., Gong, N., Mosley, R.L., Dou, H., Boska, M.D. and Gendelman, H.E. (2009) 'Facilitated monocyte-macrophage uptake and tissue distribution of superparmagnetic iron-oxide nanoparticles', PLoS One, Vol. 4, No. 2, p.e4343.
167. Moore, A., Marecos, E., Bogdanov, A. and Weissleder, R. (2000) 'Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model', Radiology, Vol. 214, No. 2, pp.568-574.
168. Popovtzer, R., Agrawal, A., Kotov, N.A., Popovtzer, A., Balter, J., Carey, T.E. and Kopelman, R. (2008) 'Targeted gold nanoparticles enable molecular CT imaging of cancer', Nano Lett., Vol. 8, No. 12, pp.4593-4596.
169. Wang, C., Chen, J., Talavage, T. and Irudayaraj, J. (2009) 'Gold nanorod/Fe3O4 nanoparticle 'nano-pearl-necklaces' for simultaneous targeting, dual-mode imaging, and photothermal ablation of cancer cells', Angew. Chem. Int. Ed. Engl., Vol. 48, No. 15, pp.2759-2763.
170. Jain, T.K., Richey, J., Strand, M., Leslie-Pelecky, D.L., Flask, C.A. and Labhasetwar, V. (2008) 'Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging', Biomaterials, Vol. 29, No. 29, pp.4012-4021.
171. Wang, J.M., Xiao, B.L., Zheng, J.W., Chen, H.B. and Zou, S.Q. (2007) 'Effect of targeted magnetic nanoparticles containing 5-FU on expression of bcl-2, bax and caspase 3 in nude mice with transplanted human liver cancer', World J. Gastroenterol., Vol. 13, No. 23, pp.3171-3175.
172. Sun, C., Fang, C., Stephen, Z., Veiseh, O., Hansen, S., Lee, D., Ellenbogen, R.G., Olson, J. and Zhang, M. (2008) 'Tumor-targeted drug delivery and MRI contrast enhancement by chlorotoxin-conjugated iron oxide nanoparticles', Nanomedicine, Vol. 3, No. 4, pp.495-505.
173. Banerjee, S.S. and Chen, D.H. (2009) 'A multifunctional magnetic nanocarrier bearing fluorescent dye for targeted drug delivery by enhanced two-photon triggered release', Nanotechnology, Vol. 20, No. 18, p185103.
174. Mikhaylova, M., Stasinopoulos, I., Kato, Y., Artemov, D. and Bhujwalla, Z.M. (2009) 'Imaging of cationic multifunctional liposome-mediated delivery of COX-2 siRNA', Cancer Gene Ther., Vol. 16, No. 3, pp.217-226.
175. Weng, K.C., Noble, C.O., Papahadjopoulos-Sternberg, B., Chen, F.F., Drummond, D.C., Kirpotin, D.B., Wang, D., Hom, Y.K., Hann, B. and Park, J.W. (2008) 'Targeted tumor cell internalization and imaging of multifunctional quantum dot-conjugated immunoliposomes in vitro and in vivo', Nano Lett., Vol. 8, No. 9, pp.2851-2857.
176. Elbayoumi, T.A., Pabba, S., Roby, A. and Torchilin, V.P. (2007) 'Antinucleosome antibody-modified liposomes and lipid-core micelles for tumor-targeted delivery of therapeutic and diagnostic agents', J. Liposome Res., Vol. 17, No. 1, pp.1-14.
177. Elbayoumi, T.A. and Torchilin, V.P. (2006) 'Enhanced accumulation of long-circulating liposomes modified with the nucleosome-specific monoclonal antibody 2C5 in various tumours in mice: gamma-imaging studies', Eur. J. Nucl. Med. Mol. Imaging, Vol. 33, No. 10, pp.1196-1205.
178. Erdogan, S., Roby, A. and Torchilin, V.P. (2006) 'Enhanced tumor visualization by gammascintigraphy with 111In-labeled polychelating-polymer- containing immunoliposomes', Mol. Pharm., Vol. 3, No. 5, pp.525-530.
179. Erdogan, S., Medarova, Z.O., Roby, A., Moore, A. and Torchilin, V.P. (2008) 'Enhanced tumor MR imaging with gadolinium-loaded polychelating polymer-containing tumor-targeted liposomes', J. Magn. Reson. Imaging, Vol. 27, No. 3, pp.574-580.
180. Vasir, J.K. and Labhasetwar, V. (2007) 'Biodegradable nanoparticles for cytosolic delivery of therapeutics', Adv. Drug Delivery Rev., Vol. 59, No. 8, pp.718-728.
181. Elbayoumi, T.A. and Torchilin, V.P. (2008) 'Liposomes for targeted delivery of antithrombotic drugs', Expert Opin. Drug Deliv., Vol. 5, No. 11, pp.1185-1198.
182. Vijayaraghavalu, S., Raghavan, D. and Labhasetwar, V. (2007) 'Nanoparticles for delivery of chemotherapeutic agents to tumors', Curr. Opin. Invest. Drugs, Vol. 8, No. 6, pp.477-484.
183. Jin, S. and Labhasetwar, V. (2009) 'Nanotechnology in urology', Urol. Clin. North Am., Vol. 36, No. 2, pp.179-188, viii.
184. Rao, K.S., Ghorpade, A. and Labhasetwar, V. (2009) 'Targeting anti-HIV drugs to the CNS', Expert Opin. Drug Deliv., Vol. 6, No. 8, pp.771-784.
185. Gilmore, J.L., Yi, X., Quan, L. and Kabanov, A.V. (2008) 'Novel nanomaterials for clinical neuroscience', J. Neuroimmune Pharmacol., Vol. 3, No. 2, pp.83-94.
186. Sawant, R.R., Sawant, R.M. and Torchilin, V.P. (2008) 'Mixed PEG-PE/vitamin E tumor-targeted immunomicelles as carriers for poorly soluble anti-cancer drugs: improved drug solubilization and enhanced in vitro cytotoxicity', Eur. J. Pharm. Biopharm., Vol. 70, No. 1, pp.51-57.
187. Patil, Y.B., Toti, U.S., Khdair, A., Ma, L. and Panyam, J. (2009) 'Single-step surface functionalization of polymeric nanoparticles for targeted drug delivery', Biomaterials, Vol. 30, No. 5, pp.859-866.
188. Rao, K.S., Reddy, M.K., Horning, J.L. and Labhasetwar, V. (2008) 'TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs', Biomaterials, Vol. 29, No. 33, pp.4429-4438.
189. Jayanna, P.K., Torchilin, V.P. and Petrenko, V.A. (2009) 'Liposomes targeted by fusion phage proteins', Nanomedicine, Vol. 5, No. 1, pp.83-89.
190. Chavanpatil, M.D., Khdair, A. and Panyam, J. (2007) 'Surfactant-polymer nanoparticles: a novel platform for sustained and enhanced cellular delivery of water-soluble molecules', Pharm. Res., Vol. 24, No. 4, pp.803-810.
191. Chavanpatil, M.D., Khdair, A., Patil, Y., Handa, H., Mao, G. and Panyam, J. (2007) 'Polymer-surfactant nanoparticles for sustained release of water-soluble drugs', J. Pharm. Sci., Vol. 96, No. 12, pp.3379-3389.
192. Bangham, A.D., Standish, M.M. and Watkins, J.C. (1965) 'Diffusion of univalent ions across the lamellae of swollen phospholipids', J. Mol. Biol., Vol. 13, No. 1, pp.238-252.
193. Langer, R. and Folkman, J. (1976) 'Polymers for the sustained release of proteins and other macromolecules', Nature, Vol. 263, No. 5580, pp.797-800.
194. Wu, X., Biatry, B., Cazeneuve, C. and Guy, R.H. (2009) 'Drug delivery to the skin from sub-micron polymeric particle formulations: influence of particle size and polymer hydrophobicity', Pharm. Res., Vol. 26, No. 8, pp.1995-2001.
195. Wu, X., Griffin, P., Price, G.J. and Guy, R.H. (2009) 'Preparation and in vitro evaluation of topical formulations based on polystyrene-poly-2-hydroxyl methacrylate nanoparticles', Mol. Pharm., Vol. 6, No. 5, pp.1449-1456.
196. Kroll, R.A., Pagel, M.A., Muldoon, L.L., Roman-Goldstein, S., Fiamengo, S.A. and Neuwelt, E.A. (1998) 'Improving drug delivery to intracerebral tumor and surrounding brain in a rodent model: a comparison of osmotic versus bradykinin modification of the blood-brain and/or blood-tumor barriers', Neurosurgery, Vol. 43, No. 4, pp.879-886; discussion 886-889.
197. Desai, M.P., Labhasetwar, V., Walter, E., Levy, R.J. and Amidon, G.L. (1997) 'The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent', Pharm. Res., Vol. 14, No. 11, pp.1568-1573.
198. Redhead, H.M., Davis, S.S. and Illum, L. (2001) 'Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation', J. Control Release, Vol. 70, No. 3, pp.353-363.
199. Yow, H.N., Wu, X., Routh, A.F. and Guy, R.H. (2009) 'Dye diffusion from microcapsules with different shell thickness into mammalian skin', Eur. J. Pharm. Biopharm., Vol. 72, No. 1, pp.62-68.
200. Yang, Z.R., Wang, H.F., Zhao, J., Peng, Y.Y., Wang, J., Guinn, B.A. and Huang, L.Q. (2007) 'Recent developments in the use of adenoviruses and immunotoxins in cancer gene therapy', Cancer Gene Ther., Vol. 14, No. 7, pp.599-615.
201. Rochlitz, C.F. (2001) 'Gene therapy of cancer', Swiss Med. Wkly., Vol. 131, Nos. 1-2, pp.4-9.
202. Ko, Y.T., Falcao, C. and Torchilin, V.P. (2009) 'Cationic liposomes loaded with proapoptotic peptide D-(KLAKLAK)(2) and Bcl-2 antisense oligodeoxynucleotide G3139 for enhanced anticancer therapy', Mol. Pharm., Vol. 6, No. 3, pp.971-977.
203. Kaplitt, M.G., Feigin, A., Tang, C., Fitzsimons, H.L., Mattis, P., Lawlor, P.A., Bland, R.J., Young, D., Strybing, K., Eidelberg, D. and During, M.J. (2007) 'Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial', Lancet, Vol. 369, No. 9579, pp.2097-2105.
204. Cavazzana-Calvo, M., Hacein-Bey, S., de Saint Basile, G., Gross, F., Yvon, E., Nusbaum, P., Selz, F., Hue, C., Certain, S., Casanova, J.L., Bousso, P., Deist, F.L. and Fischer, A. (2000) 'Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease', Science, Vol. 288, No. 5466, pp.669-672. (Pubitemid 30241569)
205. Niven, R., Pearlman, R., Wedeking, T., Mackeigan, J., Noker, P., Simpson-Herren, L. and Smith, J.G. (1998) 'Biodistribution of radiolabeled lipid-DNA complexes and DNA in mice', J. Pharm. Sci., Vol. 87, No. 11, pp.1292-1299. (Pubitemid 28514130)
206. Li, S.D. and Huang, L. (2008) 'Targeted delivery of siRNA by nonviral vectors: lessons learned from recent advances', Curr. Opin. Invest. Drugs, Vol. 9, No. 12, pp.1317-1323.
207. Chen, Y. and Huang, L. (2008) 'Tumor-targeted delivery of siRNA by non-viral vector: safe and effective cancer therapy', Expert Opin. Drug Deliv., Vol. 5, No. 12, pp.1301-1311.
208. Gao, K. and Huang, L. (2009) 'Nonviral methods for siRNA delivery', Mol. Pharm., Vol. 6, No. 3, pp.651-658.
209. Li, S.D. and Huang, L. (2009) 'Nanoparticles evading the reticuloendothelial system: role of the supported bilayer', Biochim. Biophys. Acta, Vol. 1788, No. 10, pp.2259-2266.
210. Chono, S., Li, S.D., Conwell, C.C. and Huang, L. (2008) 'An efficient and low immunostimulatory nanoparticle formulation for systemic siRNA delivery to the tumor', J. Control Release, Vol. 131, No. 1, pp.64-69.
211. Patil, Y. and Panyam, J. (2009) 'Polymeric nanoparticles for siRNA delivery and gene silencing', Int. J. Pharm., Vol. 367, Nos. 1-2, pp.195-203.
212. Li, S.D., Chono, S. and Huang, L. (2008) 'Efficient gene silencing in metastatic tumor by siRNA formulated in surface-modified nanoparticles', J. Control Release, Vol. 126, No. 1, pp.77-84.
213. Li, S.D., Chono, S. and Huang, L. (2008) 'Efficient oncogene silencing and metastasis inhibition via systemic delivery of siRNA', Mol. Ther., Vol. 16, No. 5, pp.942-946.
214. Li, S.D., Chen, Y.C., Hackett, M.J. and Huang, L. (2008) 'Tumor-targeted delivery of siRNA by self-assembled nanoparticles', Mol. Ther., Vol. 16, No. 1, pp.163-169.
215. Behr, J.P. (1993) 'Synthetic gene-transfer vectors', Acc. Chem. Res., Vol. 26, pp.274-278.
216. Verma, I.M. and Somia, N. (1997) 'Gene therapy - promises, problems and prospects', Nature, Vol. 389, No. 6648, pp.239-242.
217. Li, S.D. and Huang, L. (2007) 'Non-viral is superior to viral gene delivery', J. Control Release, Vol. 123, No. 3, pp.181-183.
218. Liu, F., Conwell, C.C., Yuan, X., Shollenberger, L.M. and Huang, L. (2007) 'Novel nonviral vectors target cellular signaling pathways: regulated gene expression and reduced toxicity', J. Pharmacol. Exp. Ther., Vol. 321, No. 2, pp.777-783.
219. Conwell, C.C., Liu, F. and Huang, L. (2008) 'Several serum proteins significantly decrease inflammatory response to lipid-based non-viral vectors', Mol. Ther., Vol. 16, No. 2, pp.370-377.
220. Grill, A.E., Johnston, N.W., Sadhukha, T. and Panyam, J. (2009) 'A review of select recent patents on novel nanocarriers', Recent Pat. Drug Deliv. Formul., Vol. 3, No. 2, pp.137-142.